Rob Cunningham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rob Cunningham has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Les Hagen
Action on Smoking & Health (ASH Canada), Edmonton, AB, Canada
2 shared publications - Michael Chaiton
Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
2 shared publications - Andrew L. Pipe
Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
1 shared publication - Cynthia Callard
Phys Smoke Free Canada, Ottawa, ON, Canada
1 shared publication - Elizabeth A. Eisenhauer
Department of Oncology, Queen’s University, Kingston, ON K7L 2V7, Canada
1 shared publication - Geoffrey T. Fong
School of Psychology, University of Waterloo, Waterloo, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 25 April 2023
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 9 (Supplement)
Innovations in Canada That May Inform the Next EU Tobacco Products Directive
Introduction: This presentation will outline, with images, the successful Canadian experience with a series of innovative regulatory measures, often world firsts. These innovative measures and this experience could be considered for the next EU Directive. Material and Methods: The...
- 25 April 2023
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 9 (Supplement)
Open AccessInnovations in Canada That May Inform the Next EU Tobacco Products Directive
Introduction: This presentation will outline, with images, the successful Canadian experience with a series of innovative regulatory measures, often world firsts. These innovative measures and this experience could be considered for the next EU Directive. Material and Methods: The...
- Open Access
- 18 March 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (3) , 2081-2090
Perspective on Cancer Control: Whither the Tobacco Endgame for Canada?
Aims: In 2014, in response to evidence that Canada’s tobacco use would lead, inexorably, to substantial morbidity and mortality for the foreseeable future, a group of experts convened to consider the development of a “Tobacco Endgame” for Canada. The “Tobacco Endgame” defines a time frame in which to eliminate structural, political, and social dynamics that sustain tobacco use, leading to improved population health. Strategies: A series of Background Papers describing possible measures that could contribute to the creation of a comprehensive endgame strategy for Canada was prepared in advance of the National Tobacco Endgame Summit hosted at Queen’s University in 2016. At the summit, agreement was reached to work together to achieve ongoing policy developments, including full implementation of the key demand-reduction policies of the WHO Framework Convention on Tobacco Control. Formidable, new disruptive policies and regulations will be needed to achieve Canada’s Endgame goal.
- 18 March 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (3) , 2081-2090
Open AccessPerspective on Cancer Control: Whither the Tobacco Endgame for Canada?
Aims: In 2014, in response to evidence that Canada’s tobacco use would lead, inexorably, to substantial morbidity and mortality for the foreseeable future, a group of experts convened to consider the development of a “Tobacco Endgame” for Canada. The “Tobacco Endgame” defines a time frame in which to eliminate structural, political, and social dynamics that sustain tobacco use, leading to improved population health. Strategies: A series of Background Papers describing possible measures that could contribute to the creation of a comprehensive endgame strategy for Canada was prepared in advance of the National Tobacco Endgame Summit hosted at Queen’s University in 2016. At the summit, agreement was reached to work together to achieve ongoing policy developments, including full implementation of the key demand-reduction policies of the WHO Framework Convention on Tobacco Control. Formidable, new disruptive policies and regulations will be needed to achieve Canada’s Endgame goal.
- Open Access
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 202-211
Taking global leadership in banning menthol and other flavours in tobacco: Canada’s experience
Measures to ban or restrict menthol and other flavours in tobacco products are under consideration or newly implemented in an increasing number of jurisdictions across the world. As one of the world leaders, Canada’s experience in successfully developing and implementing such measures can be instructive for other jurisdictions. This paper explores the history of how Canada was able to implement tobacco flavour bans including menthol, examines some of the challenges and presents lessons learnt for other jurisdictions. The crucial motivation for these bans emerged from surveillance data showing high rates of flavoured tobacco use by youth, including menthol cigarette smoking, that was publicised by non-governmental organisations. Further data showed that early legislation in 2009 contained loopholes (cigar size exemptions and menthol exemptions) that limited the benefits of the legislation. Leadership by the provinces created an environment in which the federal ban on menthol ingredients in 2017 was a clear and obvious step to ensure implementation across the country. The Canadian measures have been successful at reducing the use of flavoured tobacco including menthol cigarettes and facilitating smoking cessation. Lessons learnt include the downsides of exemptions, the lack of a contraband issue (despite an existing supply in Canada), the benefits of availability of youth flavour prevalence data and the success of subnational regulations to advance national regulation.
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 202-211
Open AccessTaking global leadership in banning menthol and other flavours in tobacco: Canada’s experience
Measures to ban or restrict menthol and other flavours in tobacco products are under consideration or newly implemented in an increasing number of jurisdictions across the world. As one of the world leaders, Canada’s experience in successfully developing and implementing such measures can be instructive for other jurisdictions. This paper explores the history of how Canada was able to implement tobacco flavour bans including menthol, examines some of the challenges and presents lessons learnt for other jurisdictions. The crucial motivation for these bans emerged from surveillance data showing high rates of flavoured tobacco use by youth, including menthol cigarette smoking, that was publicised by non-governmental organisations. Further data showed that early legislation in 2009 contained loopholes (cigar size exemptions and menthol exemptions) that limited the benefits of the legislation. Leadership by the provinces created an environment in which the federal ban on menthol ingredients in 2017 was a clear and obvious step to ensure implementation across the country. The Canadian measures have been successful at reducing the use of flavoured tobacco including menthol cigarettes and facilitating smoking cessation. Lessons learnt include the downsides of exemptions, the lack of a contraband issue (despite an existing supply in Canada), the benefits of availability of youth flavour prevalence data and the success of subnational regulations to advance national regulation.
- Open Access
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 272-283
Tobacco package health warnings: a global success story
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 272-283
Open AccessTobacco package health warnings: a global success story